Disease relevance of Condoms, Female

• The newer polyurethane male and female condoms provide alternative, safe barrier protection, although their efficacy at preventing HIV in vivo needs further study [1].

High impact information on Condoms, Female

• In 1996-1998, the authors measured prostate-specific antigen (PSA) in vaginal fluid to assess the frequency of female condom failure and to evaluate the association of self-reported failure with semen exposure [2].
• Female condom use among injection drug- and crack cocaine-using women [3].
• STUDY DESIGN: One hundred and four sexually active women with vaginal trichomoniasis were treated with metronidazole and assigned to a group using the female condom or a control group during a 45-day period of continued sexual activity [4].
• Performance of the Reality polyurethane female condom and a synthetic latex prototype: a randomized crossover trial among South African women [5].
• Short-term acceptability of the Reality polyurethane female condom and a synthetic latex prototype: a randomized crossover trial among South African women [6].

Biological context of Condoms, Female

• Structural integrity of the polyurethane female condom after multiple cycles of disinfection, washing, drying and relubrication [7].

Associations of Condoms, Female with chemical compounds

• Correlates of intention to use the female condom among women taking methadone [8].
• The intervention condition received barrier products (male and female condoms and spermicides based on nonoxynol-9 in the form of vaginal gel, film, and suppositories) during three sessions held over 3 months [9].
• New progestin oral contraceptives and the female condom [10].
• This article describes both barrier and spermicide methods of contraception including the male and female condom, diaphragm, contraceptive sponge, Lea Shield, cervical cap and multiple spermicide options [11].
• The female condom is the latest in a series of sexual and reproductive technologies to be imported into the third world, following the contraceptive pill, the Depo-Provera injection, the latex male condom, and others [12].

Gene context of Condoms, Female

• Acceptability of the female condom amongst commercial sex workers in Thailand and Côte d'Ivoire [13].
• SETTING: Groote Schuur and Somerset Hospitals, Cape Town. PARTICIPANTS: Nurses, secretaries, doctors and domestic staff of Groote Schuur and Somerset Hospitals who volunteered-61 women were recruited, 8 did not use any female condoms, and 1 did not return [14].

References